The agency indicated that, in order for such drugs to be covered, patients with Medicare Part B must be enrolled in registries that collect real-world data on the treatment’s effectiveness. 

Bullying and other inappropriate workplace behaviors have been linked to an increased risk of errors and worse patient outcomes. 

Samuel Jones, MD, examines the large reimbursement reductions in cardiac ablations and what the impact might be on access to care in EP labs.

Production of Integra’s SurgiMend, PriMatrix, Revize and TissueMend products has been temporarily halted due to the recalls, although the company said it has not received any customer complaints. 

The FDA’s process of reviewing and approving drugs and devices could be put on hold, if lawmakers fail to reach a deal related to the debt ceiling.

The Biden Administration has refreshed its efforts to encourage AI innovation while mitigating AI risks.

The new policy statement warns that any inaccurate or misleading claims to consumers about how their data is collected and used will be considered a violation of the FTC Act.

Although commercial payors do offer better reimbursement rates, their lack of timeliness in making payments is negatively impacting hospitals.